Age, median (range) ≥ 50 years	55 (19-72) 39 (61)
Sex, male	34 (53)
Underlying disease AL and MDS NHL/Hodgkin Myelofibrosis or other MPN Others	33 (51) 15 (23) 9 (14) 7 (11)
Advanced disease at transplant	27 (42)
Sex mismatch: female to male	8 (12)
Donor type HLA Identical Sibling 10/10 matched URD / 1-allele mismatched URD	19 (30) 20/25(31/39)
Disease risk index: High/Very high	12 (41)
Conditioning Fludarabine-Busulphan (RIC) Fludarabine-Melphalan (RIC) MiniTiothepa-modified RICs Fludarabine- TBI or Busulphan (MAC)	11 (17) 13 (20) 23 (36) 17 (26)
Stem cell source (PBSC)	62 (97)
Second immunosuppressive agent: Single-agent Tacrolimus/Sirolimus	61/3(95/5)